1. Home
  2. MTNB vs ACXP Comparison

MTNB vs ACXP Comparison

Compare MTNB & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTNB
  • ACXP
  • Stock Information
  • Founded
  • MTNB 2013
  • ACXP 2017
  • Country
  • MTNB United States
  • ACXP United States
  • Employees
  • MTNB N/A
  • ACXP 4
  • Industry
  • MTNB Biotechnology: Pharmaceutical Preparations
  • ACXP Biotechnology: Pharmaceutical Preparations
  • Sector
  • MTNB Health Care
  • ACXP Health Care
  • Exchange
  • MTNB Nasdaq
  • ACXP Nasdaq
  • Market Cap
  • MTNB 16.1M
  • ACXP 30.7M
  • IPO Year
  • MTNB N/A
  • ACXP 2021
  • Fundamental
  • Price
  • MTNB $2.40
  • ACXP $1.89
  • Analyst Decision
  • MTNB
  • ACXP Strong Buy
  • Analyst Count
  • MTNB 0
  • ACXP 1
  • Target Price
  • MTNB N/A
  • ACXP $12.00
  • AVG Volume (30 Days)
  • MTNB 40.3K
  • ACXP 36.8K
  • Earning Date
  • MTNB 11-06-2024
  • ACXP 11-13-2024
  • Dividend Yield
  • MTNB N/A
  • ACXP N/A
  • EPS Growth
  • MTNB N/A
  • ACXP N/A
  • EPS
  • MTNB N/A
  • ACXP N/A
  • Revenue
  • MTNB N/A
  • ACXP N/A
  • Revenue This Year
  • MTNB N/A
  • ACXP N/A
  • Revenue Next Year
  • MTNB N/A
  • ACXP N/A
  • P/E Ratio
  • MTNB N/A
  • ACXP N/A
  • Revenue Growth
  • MTNB N/A
  • ACXP N/A
  • 52 Week Low
  • MTNB $2.52
  • ACXP $1.52
  • 52 Week High
  • MTNB $21.50
  • ACXP $5.70
  • Technical
  • Relative Strength Index (RSI)
  • MTNB 32.40
  • ACXP 42.98
  • Support Level
  • MTNB $2.52
  • ACXP $1.81
  • Resistance Level
  • MTNB $3.35
  • ACXP $1.96
  • Average True Range (ATR)
  • MTNB 0.33
  • ACXP 0.07
  • MACD
  • MTNB -0.03
  • ACXP -0.01
  • Stochastic Oscillator
  • MTNB 16.14
  • ACXP 30.52

About MTNB Matinas Biopharma Holdings Inc.

Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration.

Share on Social Networks: